TrialBlood advances2021

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).

Alison R Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.